Trial Profile
Multicenter phase II study of panitumumab, docetaxel, 5-FU, leucovorin and oxaliplatin (P-FLOT) in patients with metastatic or locally advanced Kras wild type adenocarcinoma of the stomach or the gastroesophageal junction
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2013
Price :
$35
*
At a glance
- Drugs Panitumumab (Primary) ; Docetaxel; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 03 Sep 2013 New trial record